Neuroleptic effects on regional brain metabolism in first episode schizophrenics.
Cleghorn
J M
JM
Department of Psychiatry, McMaster University, Faculty of Health Sciences, Hamilton, Ontario, Canada.
Szechtman
H
H
Garnett
E S
ES
Brown
G M
GM
Nahmias
C
C
Szechtman
B
B
Kaplan
R
R
Franco
S
S
D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001786:Blood Glucose / Q000378:metabolism*; D001921:Brain / Q000000981:diagnostic imaging / Q000187:drug effects; D003847:Deoxyglucose / Q000031:analogs & derivatives / Q000378:metabolism; D004734:Energy Metabolism / Q000187:drug effects* / Q000502:physiology*; D005260:Female; D019788:Fluorodeoxyglucose F18; D005500:Follow-Up Studies; D005625:Frontal Lobe / Q000000981:diagnostic imaging / Q000187:drug effects; D006801:Humans; D008297:Male; D019965:Neurocognitive Disorders / Q000000981:diagnostic imaging* / Q000188:drug therapy* / Q000503:physiopathology; D010296:Parietal Lobe / Q000000981:diagnostic imaging / Q000187:drug effects; D012559:Schizophrenia / Q000000981:diagnostic imaging* / Q000188:drug therapy* / Q000503:physiopathology; D012565:Schizophrenic Psychology; D014055:Tomography, Emission-Computed
D014150:Antipsychotic Agents; D001786:Blood Glucose; D019788:Fluorodeoxyglucose F18; D003847:Deoxyglucose